Winton Group’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,688
| Closed | -$1.23M | – | 744 |
|
|
2024
Q3 | $1.23M | Sell |
54,688
-11,966
| -18% | -$269K | 0.09% | 194 |
|
|
2024
Q2 | $1.12M | Sell |
66,654
-1,403
| -2% | -$23.5K | 0.08% | 192 |
|
|
2024
Q1 | $880K | Buy |
68,057
+29,916
| +78% | +$387K | 0.06% | 342 |
|
|
2023
Q4 | $442K | Buy |
38,141
+20,850
| +121% | +$241K | 0.03% | 372 |
|
|
2023
Q3 | $221K | Buy |
17,291
+901
| +5% | +$11.5K | 0.02% | 632 |
|
|
2023
Q2 | $225K | Sell |
16,390
-194
| -1% | -$2.66K | 0.02% | 629 |
|
|
2023
Q1 | $254K | Sell |
16,584
-6,335
| -28% | -$97.1K | 0.02% | 856 |
|
|
2022
Q4 | $307K | Buy |
22,919
+1,766
| +8% | +$23.7K | 0.02% | 779 |
|
|
2022
Q3 | $281K | Buy |
21,153
+3,765
| +22% | +$50K | 0.02% | 816 |
|
|
2022
Q2 | $333K | Buy |
17,388
+1,942
| +13% | +$37.2K | 0.02% | 788 |
|
|
2022
Q1 | $308K | Buy |
15,446
+1,642
| +12% | +$32.7K | 0.02% | 808 |
|
|
2021
Q4 | $282K | Sell |
13,804
-13,498
| -49% | -$276K | 0.02% | 851 |
|
|
2021
Q3 | $588K | Sell |
27,302
-712
| -3% | -$15.3K | 0.03% | 776 |
|
|
2021
Q2 | $809K | Buy |
28,014
+2,634
| +10% | +$76.1K | 0.04% | 645 |
|
|
2021
Q1 | $619K | Buy |
25,380
+1,192
| +5% | +$29.1K | 0.04% | 752 |
|
|
2020
Q4 | $470K | Sell |
24,188
-3,737
| -13% | -$72.6K | 0.03% | 822 |
|
|
2020
Q3 | $486K | Sell |
27,925
-1,139
| -4% | -$19.8K | 0.02% | 1128 |
|
|
2020
Q2 | $764K | Sell |
29,064
-52,949
| -65% | -$1.39M | 0.02% | 1072 |
|
|
2020
Q1 | $1.98M | Sell |
82,013
-4,851
| -6% | -$117K | 0.05% | 581 |
|
|
2019
Q4 | $2.16M | Buy |
86,864
+32,558
| +60% | +$808K | 0.03% | 767 |
|
|
2019
Q3 | $1.16M | Buy |
54,306
+42,760
| +370% | +$912K | 0.01% | 764 |
|
|
2019
Q2 | $367K | Buy |
+11,546
| New | +$367K | 0.01% | 804 |
|